These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 11602820)
1. Drug block of I(kr): model systems and relevance to human arrhythmias. Yang T; Snyders D; Roden DM J Cardiovasc Pharmacol; 2001 Nov; 38(5):737-44. PubMed ID: 11602820 [TBL] [Abstract][Full Text] [Related]
2. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Redfern WS; Carlsson L; Davis AS; Lynch WG; MacKenzie I; Palethorpe S; Siegl PK; Strang I; Sullivan AT; Wallis R; Camm AJ; Hammond TG Cardiovasc Res; 2003 Apr; 58(1):32-45. PubMed ID: 12667944 [TBL] [Abstract][Full Text] [Related]
3. High affinity open channel block by dofetilide of HERG expressed in a human cell line. Snyders DJ; Chaudhary A Mol Pharmacol; 1996 Jun; 49(6):949-55. PubMed ID: 8649354 [TBL] [Abstract][Full Text] [Related]
4. Modulation of HERG potassium channels by extracellular magnesium and quinidine. Po SS; Wang DW; Yang IC; Johnson JP; Nie L; Bennett PB J Cardiovasc Pharmacol; 1999 Feb; 33(2):181-5. PubMed ID: 10028924 [TBL] [Abstract][Full Text] [Related]
6. Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides. Spector PS; Curran ME; Keating MT; Sanguinetti MC Circ Res; 1996 Mar; 78(3):499-503. PubMed ID: 8593709 [TBL] [Abstract][Full Text] [Related]
7. [Electropharmacological assessment of the risk of drug-induced long-QT syndrome using native cardiac cells and cultured cells expressing HERG channels]. Nakaya H Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):384-92. PubMed ID: 12835532 [TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel. Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182 [TBL] [Abstract][Full Text] [Related]
9. Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline. Jo SH; Youm JB; Lee CO; Earm YE; Ho WK Br J Pharmacol; 2000 Apr; 129(7):1474-80. PubMed ID: 10742304 [TBL] [Abstract][Full Text] [Related]
10. Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics. Anderson ME; Mazur A; Yang T; Roden DM J Pharmacol Exp Ther; 2001 Mar; 296(3):806-10. PubMed ID: 11181910 [TBL] [Abstract][Full Text] [Related]
11. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia. Scherer CR; Lerche C; Decher N; Dennis AT; Maier P; Ficker E; Busch AE; Wollnik B; Steinmeyer K Br J Pharmacol; 2002 Nov; 137(6):892-900. PubMed ID: 12411421 [TBL] [Abstract][Full Text] [Related]
12. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872. Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067 [TBL] [Abstract][Full Text] [Related]
13. Physicochemical determinants for drug induced blockade of HERG potassium channels: effect of charge and charge shielding. Zolotoy AB; Plouvier BP; Beatch GB; Hayes ES; Wall RA; Walker MJ Curr Med Chem Cardiovasc Hematol Agents; 2003 Oct; 1(3):225-41. PubMed ID: 15326914 [TBL] [Abstract][Full Text] [Related]
14. The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations. Ficker E; Obejero-Paz CA; Zhao S; Brown AM J Biol Chem; 2002 Feb; 277(7):4989-98. PubMed ID: 11741928 [TBL] [Abstract][Full Text] [Related]
15. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG. Rampe D; Roy ML; Dennis A; Brown AM FEBS Lett; 1997 Nov; 417(1):28-32. PubMed ID: 9395068 [TBL] [Abstract][Full Text] [Related]
16. Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide. Ridley JM; Milnes JT; Benest AV; Masters JD; Witchel HJ; Hancox JC Biochem Biophys Res Commun; 2003 Jun; 306(2):388-93. PubMed ID: 12804575 [TBL] [Abstract][Full Text] [Related]
17. Molecular determinants of dofetilide block of HERG K+ channels. Ficker E; Jarolimek W; Kiehn J; Baumann A; Brown AM Circ Res; 1998 Feb; 82(3):386-95. PubMed ID: 9486667 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of block and identification of the verapamil binding domain to HERG potassium channels. Zhang S; Zhou Z; Gong Q; Makielski JC; January CT Circ Res; 1999 May; 84(9):989-98. PubMed ID: 10325236 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels. Kiehn J; Thomas D; Karle CA; Schöls W; Kübler W Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):212-9. PubMed ID: 10208308 [TBL] [Abstract][Full Text] [Related]
20. Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. Volberg WA; Koci BJ; Su W; Lin J; Zhou J J Pharmacol Exp Ther; 2002 Jul; 302(1):320-7. PubMed ID: 12065733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]